|
1
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rattan R, Giri S, Hartmann LC and Shridhar
V: Metformin attenuates ovarian cancer cell growth in an AMP-kinase
dispensable manner. J Cell Mol Med. 15:166–178. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Karimi P, Islami F, Anandasabapathy S,
Freedman ND and Kamangar F: Gastric cancer: Descriptive
epidemiology, risk factors, screening, and prevention. Cancer
Epidemiol Biomarkers Prev. 23:700–713. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen W, Zheng R, Zhang S, Zhao P, Zeng H,
Zou X and He J: Annual report on status of cancer in China, 2010.
Chin J Cancer Res. 26:48–58. 2014.PubMed/NCBI
|
|
5
|
Xiao X, Hao M, Yang XY, Ba Q, Li M, Ni SJ,
Wang LS and Du X: Licochalcone A inhibits growth of gastric cancer
cells by arresting cell cycle progression and inducing apoptosis.
Cancer Lett. 302:69–75. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kataoka Y, Mukohara T, Tomioka H,
Funakoshi Y, Kiyota N, Fujiwara Y, Yashiro M, Hirakawa K, Hirai M
and Minami H: Foretinib (GSK1363089), a multi-kinase inhibitor of
MET and VEGFRs, inhibits growth of gastric cancer cell lines by
blocking inter-receptor tyrosine kinase networks. Invest New Drugs.
30:1352–1360. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Masoud GN and Li W: HIF-1α pathway: Role,
regulation and intervention for cancer therapy. Acta Pharm Sin.
5:378–389. 2015. View Article : Google Scholar
|
|
8
|
Harris AL: Hypoxia-a key regulatory factor
in tumour growth. Nat Rev Cancer. 2:38–45. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stoeltzing O, McCarty MF, Wey JS, Fan F,
Liu W, Belcheva A, Bucana CD, Semenza GL and Ellis LM: Role of
hypoxia-inducible factor 1 alpha in gastric cancer cell growth,
angiogenesis, and vessel maturation. J Natl Cancer Inst.
96:946–956. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li L, Zhang GQ, Chen H, Zhao ZJ, Chen HZ,
Liu H, Wang G, Jia YH, Pan SH, Kong R, et al: Plasma and tumor
levels of Linc-pint are diagnostic and prognostic biomarkers for
pancreatic cancer. Oncotarget. 7:71773–71781. 2016.PubMed/NCBI
|
|
11
|
Marín-Béjar O, Mas AM, González J,
Martinez D, Athie A, Morales X, Galduroz M, Raimondi I, Grossi E,
Guo S, et al: The human lncRNA LINC-PINT inhibits tumor cell
invasion through a highly conserved sequence element. Genome Biol.
118:2022017. View Article : Google Scholar
|
|
12
|
Yang F, Zhang H, Mei Y and Wu M:
Reciprocal regulation of HIF-1α and lincRNA-p21 modulates the
Warburg effect. Mol Cell. 53:88–100. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
McLean MH and El-Omar EM: Genetics of
gastric cancer. Nat Rev Gastroenterol Hepatol. 11:664–674. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang J, Ni Z, Duan Z, Wang G and Li F:
Altered expression of hypoxia-inducible factor-1α (HIF-1α) and its
regulatory genes in gastric cancer tissues. PLoS One. 9:e998352014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao Q, Li Y, Tan B, Fan LQ, Yang PG and
Tian Y: HIF-1α induces multidrug resistance in gastric cancer cells
by inducing miR-27a. PLoS One. 10:e01327462015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang K, Shi H, Xi H, Wu X, Cui J, Gao Y,
Liang W, Hu C, Liu Y, Li J, et al: Genome-wide lncRNA microarray
profiling identifies novel circulating lncRNAs for detection of
gastric cancer. Theranostics. 7:213–227. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Luo F, Liu X, Ling M, Lu L, Shi L, Lu X,
Li J, Zhang A and Liu Q: The lncRNA MALAT1, acting through HIF-1α
stabilization, enhances arsenite-induced glycolysis in human
hepatic L-02 cells. Biochim Biophys Acta. 1862:1685–1695. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang L, Luo X, Chen F, Yuan W, Xiao X,
Zhang X, Dong Y, Zhang Y and Liu Y: LncRNA SNHG1 regulates
cerebrovascular pathologies as a competing endogenous RNA through
HIF-1α/VEGF signaling in ischemic stroke. J Cell Biochem.
119:5460–5472. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hong Q, Li O, Zheng W, Xiao WZ, Zhang L,
Wu D, Cai GY, He JC and Chen XM: LncRNA HOTAIR regulates HIF-1α/AXL
signaling through inhibition of miR-217 in renal cell carcinoma.
Cell Death Dis. 8:e27722017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Marin-Hernandez A, Gallardo-Perez JC,
Ralph SJ, Rodríguez-Enríquez S and Moreno-Sánchez R: HIF-1 alpha
modulates energy metabolism in cancer cells by inducing
over-expression of specific glycolytic isoforms. Mini Rev Med Chem.
9:1084–1101. 2009. View Article : Google Scholar : PubMed/NCBI
|
